Table 3.

Crude and adjusted hazard ratio for 5-year all-cause mortality among 1291 of heart failure ECGs.

	Crude		Multivariable adjusted
	HR (95% CI)	p value	HR (95% CI)	p value
Model 1
Age > 70	2.733 (2.269–3.291)	< 0.001	2.734 (2.192–3.411)	< 0.001
Diabetes	1.674 (1.416–1.980)	< 0.001	1.235 (1.007–1.515)	0.043
Ischemic Heart Disease	1.764 (1.486–2.094)	< 0.001	1.357 (1.106–1.665)	0.003
CKD stage 4–5	1.849 (1.464–2.336)	< 0.001	1.590 (1.250–2.023)	< 0.001
DeepECG-HFrEF (+)	1.496 (1.265–1.770)	< 0.001	1.351 (1.109–1.646)	0.003
Model 2
Age > 70	2.733 (2.269–3.291)	< 0.001	2.726 (2.184–3.403)	< 0.001
Diabetes	1.674 (1.416–1.980)	< 0.001	1.235 (1.006–1.515)	0.043
Ischemic Heart Disease	1.764 (1.486–2.094)	< 0.001	1.362 (1.110–1.673)	0.003
CKD stage 4–5	1.849 (1.464–2.336)	< 0.001	1.591 (1.251–2.023)	< 0.001
DeepECG-HFrEF (+)	1.496 (1.265–1.770)	< 0.001	1.381 (1.099–1.734)	0.006
EF < 40%	1.215 (1.027–1.438)	0.023	1.044 (0.831–1.310)	0.713
Model 3
Age > 70	2.733 (2.269–3.291)	< 0.001	2.693 (1.981–3.660)	< 0.001
Diabetes	1.674 (1.416–1.980)	< 0.001	1.016 (0.770–1.339)	0.913
Ischemic Heart Disease	1.764 (1.486–2.094)	< 0.001	1.375 (1.042–1.813)	0.024
CKD stage 4–5	1.849 (1.464–2.336)	< 0.001	1.719 (1.245–2.375)	0.001
DeepECG-HFrEF (+)	1.496 (1.265–1.770)	< 0.001	1.103 (0.837–1.453)	0.487
BNP > 500, pg/mL	1.693 (1.221–2.348)	0.002	1.585 (1.126–2.232)	0.008

BNP B-type natriuretic peptide, CI confidence interval, CKD chronic kidney disease, ECG electrocardiogram, EF ejection fraction, HR hazard ratio.